在炎症性肌病中,垂头/弯脊综合征与硬化性肌炎相关:一项国际病例对照研究
该国际病例对照研究纳入49例伴垂头/弯脊综合征的炎症性肌病患者与98例无该症状的对照,发现垂头/弯脊综合征是疾病严重度标志,与系统性硬化症相关(40.8%符合ACR/EULAR标准 vs 5.1%),且该组死亡率更高。
要点
- 垂头/弯脊综合征在炎症性肌病中提示病情更重,上肢无力、吞咽困难、肌萎缩、体重下降和丧失行走能力更常见。
- 伴垂头/弯脊综合征的炎症性肌病患者40.8%符合ACR/EULAR系统性硬化症标准,显著高于对照组的5.1%。
- 该组患者更常接受静脉注射免疫球蛋白(65.3% vs 34.7%),丧失行走能力与生存独立相关。
核心结论
- 在炎症性肌病患者中,垂头/弯脊综合征是疾病严重度的标志,并与系统性硬化症相关(硬化性肌炎)。
研究设计与样本
- 国际病例对照研究,邀请五个炎症性肌病网络中的执业医师报告伴垂头/弯脊综合征(除炎症性肌病外无其他已知病因)的炎症性肌病患者。
- 在每个参与中心随机选择不伴垂头/弯脊综合征的炎症性肌病患者作为对照,按2:1比例纳入。
- 共纳入49例伴垂头/弯脊综合征的炎症性肌病患者(垂头57.1%,弯脊42.9%)与98例对照炎症性肌病患者。
主要发现
- 伴垂头/弯脊综合征的炎症性肌病患者年龄更大(65岁 vs 53岁,p<0.0001),且炎症性肌病诊断延迟(6个月 vs 3个月,p=0.009)。
- 上肢为主的无力(42.9% vs 15.3%)、吞咽困难(57.1% vs 25.5%)、肌萎缩(65.3% vs 34.7%)、体重下降(61.2% vs 23.5%)和丧失行走能力(24.5% vs 5.1%)是伴垂头/弯脊综合征的炎症性肌病的特征(p≤0.0005)。
- 伴垂头/弯脊综合征的炎症性肌病患者更常接受静脉注射免疫球蛋白(65.3% vs 34.7%,p=0.0004)。
- 伴垂头/弯脊综合征的炎症性肌病患者常具有系统性硬化症(SSc)的体征和/或并发症,40.8%符合美国风湿病学会/欧洲抗风湿病联盟(ACR/EULAR)对该病的标准(对照组为5.1%,p<0.0001)。
- 肌病的分布、严重度及其与系统性硬化症的关联与垂头/弯脊综合征独立相关(p<0.05);伴垂头/弯脊综合征的炎症性肌病患者死亡率更高,丧失行走能力与生存独立相关(p<0.05)。
关键数值与推荐
- 伴垂头/弯脊综合征的炎症性肌病患者40.8%符合ACR/EULAR系统性硬化症标准,对照组为5.1%(p<0.0001)。
- 伴垂头/弯脊综合征的炎症性肌病患者中垂头占57.1%、弯脊占42.9%。
- 伴垂头/弯脊综合征的炎症性肌病患者年龄65岁 vs 对照组53岁(p<0.0001),诊断延迟6个月 vs 3个月(p=0.009)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Some myopathies can lead to dropped head or bent spine syndrome (DH/BS). The significance of this symptom has not been studied in inflammatory myopathies (IM). OBJECTIVES: To assess the significance of DH/BS in patients with IM. METHODS: Practitioners from five IM networks were invited to report patients with IM suffering from DH/BS (without other known cause than IM). IM patients without DH/BS, randomly selected in each participating centre, were included as controls at a ratio of 2 to 1. RESULTS: 49 DH/BS-IM patients (DH: 57.1%, BS: 42.9%) were compared with 98 control-IM patients. DH/BS-IM patients were older (65 years vs 53 years, p<0.0001) and the diagnosis of IM was delayed (6 months vs 3 months, p=0.009). Weakness prevailing in the upper limbs (42.9% vs 15.3%), dysphagia (57.1% vs 25.5%), muscle atrophy (65.3% vs 34.7%), weight loss (61.2% vs 23.5%) and loss of the ability to walk (24.5% vs 5.1%) were hallmarks of DH/BS-IM (p≤0.0005), for which the patients more frequently received intravenous immunoglobulins (65.3% vs 34.7%, p=0.0004). Moreover, DH/BS-IM patients frequently featured signs and/or complications of systemic sclerosis (SSc), fulfilling the American College of Rheumatology/European Alliance of Associations for Rheumatology criteria for this disease in 40.8% of the cases (vs 5.1%, p<0.0001). Distribution of the myopathy, its severity and its association with SSc were independently associated with DH/BS (p<0.05). Mortality was higher in the DH/BS-IM patients and loss of walking ability was independently associated with survival (p<0.05). CONCLUSION: In IM patients, DH/BS is a marker of severity and is associated with SSc (scleromyositis).
引用
- Pijnenburg L, Giannini M, Bouchard-Marmen M, et al. In inflammatory myopathies, dropped head/bent spine syndrome is associated with scleromyositis: an international case-control study. RMD Open. 2023. PMID: 37666644. doi:10.1136/rmdopen-2023-003081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。